Younger lung cancer patients more easily matched to targeted therapies

Analyzing genomic and immune data from 14,246 patients, researchers found nearly 58% ‌of younger patients ⁠had guideline-recommended actionable ⁠mutations, compared with about 45% of patients age 55 and older.

Leave a Reply